Accelerating the Future of Cell & Gene Therapy

At CytoNiche, we specialize in simplifying the complex world of CGT, especially mesenchymal stem/stromal cells (MSCs) to drive the success of therapeutic commercialization. Our solutions empower you to scale up production with cost-effective, high-quality cells, so that you can focus on what you do best —— developing transformative therapeutics. By optimizing access and affordability, we accelerate the timeline for bringing groundbreaking products to market.

See What Powers Us >

Events & News

More Events&News >

Mar 12,2026

CytoNiche Receives Top Bioprocessing Honour at ABEA 2026

Cytoniche Honoured with "Emerging Bioprocessing Supplier Award: Downstream Processing" at ABEA 2026

Mar 04,2026

CITCI – Cumbre Internacional de Terapias Celulares e Inmunológicas

3-4 September 2026 | Guadalajara, Mexico

Jan 22,2026

The Industrial Engine for NK Cell Therapy: Scaling NK Cell Therapy with 3D FloTrix™ NK Serum-Free Medium Kit (RNK59)

Unveiling the 3D FloTrix™ NK Serum Free Medium Kit, a serum-free, animal-origin-free, and antibiotic-free medium for scalable, GMP-ready NK cell manufacturing.